絞り込み

16641

広告

観測船しらせのヘリから機器投下 (デイリースポーツ)

【南大洋共同】南極・昭和基地へ向かっている観測船「しらせ」に乗る第61次南極観測隊は11日(日本時間同)、気候変動により融解が懸念されている「トッテン氷河」の沖...

  1. 東京パラ ドキュメンタリー共同制作へ I...
  2. 「スター・ウォーズ」完結編 監督や出演者...
  3. 大飯原発1・2号機の廃炉計画を認可 10...
  4. めおと漫才 宮川花子さん 多発性骨髄腫を...

ニュース一覧

1287件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib.

Afatinib in locally advanced/metastatic NSCLC harboring common mutations, after chemotherapy: a Phase IV study.

Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.

Second-line treatment of T790M-negative non-small cell lung cancer patients.

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer.

Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement.

Successful treatment of an elderly patient with an uncommon L861Q epidermal growth factor receptor mutation with low-dose afatinib: A case report.

Analysis of TGCA data reveals genetic and epigenetic changes and biological function of family genes in colorectal cancer.

[Effects of Seven Tyrosine Kinase Inhibitors on the Anticoagulation Activity of Warfarin].

Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in -Mutant Lung Adenocarcinoma.

Sensitization of HT29 colorectal cancer cells to vemurafenib in three-dimensional collagen cultures.

Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.

The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors.

Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery.

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.

Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation.

Efficacy of Afatinib and Lapatinib Against Gene-amplified Trastuzumab-sensitive and -resistant Human Gastric Cancer Cells.

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling.

Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With Mutations.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります